Trials / Completed
CompletedNCT02179736
A Post Market Evaluation After Treatment of Nasolabial Folds
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 114 (actual)
- Sponsor
- Galderma R&D · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This is an open, non-comparative study to evaluate effectiveness and safety of Restylane in correction of nasolabial folds up to 12 months after the initial treatment, and to evaluate the safety of repeat treatment of the nasolabial folds 12 months after the initial treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Restylane |
Timeline
- Start date
- 2014-07-01
- Primary completion
- 2016-01-01
- Completion
- 2016-01-01
- First posted
- 2014-07-02
- Last updated
- 2022-08-25
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT02179736. Inclusion in this directory is not an endorsement.